BRITTANY FOREMAN: Open Payments
NPI 1174908164 · MARKLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,447 in 92 payments from 24 companies in 2025. Trend: 2023 $740 · 2024 $1,052 · 2025 $1,447
Food & beverage: $1,363Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $294 |
| AstraZeneca Pharmaceuticals LP | 10 | $189 |
| Vanda Pharmaceuticals Inc. | 15 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $87 |
| Axsome Therapeutics, Inc. | 5 | $77 |
| PFIZER INC. | 3 | $62 |
| Amgen Inc. | 3 | $46 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Astellas Pharma US Inc | 2 | $41 |
Products named: VRAYLAR, CAPLYTA, FANAPT, UBRELVY, JARDIANCE, Auvelity, BREZTRI, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
